1. Home
  2. GTBP vs AMBO Comparison

GTBP vs AMBO Comparison

Compare GTBP & AMBO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GTBP
  • AMBO
  • Stock Information
  • Founded
  • GTBP 1965
  • AMBO 2000
  • Country
  • GTBP United States
  • AMBO United States
  • Employees
  • GTBP N/A
  • AMBO N/A
  • Industry
  • GTBP Biotechnology: Pharmaceutical Preparations
  • AMBO Other Consumer Services
  • Sector
  • GTBP Health Care
  • AMBO Real Estate
  • Exchange
  • GTBP Nasdaq
  • AMBO Nasdaq
  • Market Cap
  • GTBP 6.8M
  • AMBO 7.2M
  • IPO Year
  • GTBP N/A
  • AMBO 2010
  • Fundamental
  • Price
  • GTBP $2.25
  • AMBO $2.50
  • Analyst Decision
  • GTBP Strong Buy
  • AMBO
  • Analyst Count
  • GTBP 1
  • AMBO 0
  • Target Price
  • GTBP $11.00
  • AMBO N/A
  • AVG Volume (30 Days)
  • GTBP 244.8K
  • AMBO 127.6K
  • Earning Date
  • GTBP 03-25-2025
  • AMBO 12-30-2024
  • Dividend Yield
  • GTBP N/A
  • AMBO N/A
  • EPS Growth
  • GTBP N/A
  • AMBO N/A
  • EPS
  • GTBP N/A
  • AMBO N/A
  • Revenue
  • GTBP N/A
  • AMBO $7,839,000.00
  • Revenue This Year
  • GTBP N/A
  • AMBO N/A
  • Revenue Next Year
  • GTBP N/A
  • AMBO N/A
  • P/E Ratio
  • GTBP N/A
  • AMBO N/A
  • Revenue Growth
  • GTBP N/A
  • AMBO N/A
  • 52 Week Low
  • GTBP $1.72
  • AMBO $1.00
  • 52 Week High
  • GTBP $10.66
  • AMBO $6.30
  • Technical
  • Relative Strength Index (RSI)
  • GTBP 44.16
  • AMBO 49.96
  • Support Level
  • GTBP $2.01
  • AMBO $2.20
  • Resistance Level
  • GTBP $2.27
  • AMBO $2.68
  • Average True Range (ATR)
  • GTBP 0.22
  • AMBO 0.32
  • MACD
  • GTBP -0.01
  • AMBO 0.01
  • Stochastic Oscillator
  • GTBP 38.71
  • AMBO 56.51

About GTBP GT Biopharma Inc.

GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. It is engaged in discovering, developing, and commercializing novel therapeutics from its proprietary product platform in a varied range of disease areas. The company mainly develops drugs focused on the treatment of cancer. Its TriKE (Tri-specific Killer Engager) platforms offer immuno-oncology products that can treat a range of hematologic malignancies, sarcoma, and solid tumors.

About AMBO Ambow Education Holding Ltd.

Ambow Education Holding Ltd is a provider of educational and career enhancement services in China. It operates through CP&CE Programs. The CP&CE Programs include tutoring services and career enhancement services. Geographically all the operations function in the United States and Foreign countries.

Share on Social Networks: